New Treatment Could Be 'Breakthrough' for Vitiligo

Ruby February 05, 2018 Genera Health, WebMD Health

The new therapy includes the oral medication Xeljanz (tofacitinib) -- a drug already approved for use in rheumatoid arthritis patients that dampens the body's immune response -- and ultraviolet-B light therapy.

from WebMD Health http://ift.tt/2nJyXLi
http://ift.tt/2E4MpEs

No comments

Subscribe to: Post Comments ( Atom )